Literature DB >> 7318326

Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?

S E Kjeldsen, B Flaaten, I Eide, A Helgeland, P Leren.   

Abstract

1. Twenty middle-aged men with untreated sustained essential hypertension for more than 5 years and 19 comparable normotensive controls were investigated. Both groups were derived from The Oslo Study, where they had served as control hypertensive and normotensive subjects. 2. Supine venous and arterial plasma catecholamines were increased in the hypertensive subjects compared with the normotensive subjects. The mean arterial--venous difference for adrenaline in the hypertensive (0.45 +/- SE 0.08 nmol/l) was increased compared with the normotensive group (0.27 +/- 0.03 nmol/l, P less than 0.05). Similarly, the venous--arterial difference for noradrenaline was increased in the hypertensive (0.29 +/- 0.13 nmol/l, P less than 0.05) compared with the normotensive group (-0.07 +/- 0.11 nmol/l). 3. The results are consistent with an increased release of adrenaline from the adrenal medulla and noradrenaline from the peripheral vascular beds (forearm) in essential hypertension. The increased arterial--venous difference for adrenaline in the hypertensive group also suggests an increased uptake of adrenaline in the peripheral vascular beds.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318326     DOI: 10.1042/cs061215s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

Review 1.  Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.

Authors:  Alexandre Persu; Fadl Elmula M Fadl Elmula; Yu Jin; Ingrid Os; Sverre E Kjeldsen; Jan A Staessen
Journal:  Eur Cardiol       Date:  2014-12

2.  Hypertension: Renal denervation-promising data from the DENERHTN trial.

Authors:  Wen-Yi Yang; Jan A Staessen
Journal:  Nat Rev Nephrol       Date:  2015-03-10       Impact factor: 28.314

Review 3.  Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Yu Jin; Jan A Staessen
Journal:  Front Physiol       Date:  2015-02-09       Impact factor: 4.566

4.  Upregulation of the Renin-Angiotensin-aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types of hypertension.

Authors:  Hakuo Takahashi
Journal:  Int J Hypertens       Date:  2012-12-17       Impact factor: 2.420

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.